Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5

被引:156
作者
Kim, H
Kim, EH
Eom, YW
Kim, WH
Kwon, TK
Lee, SJ
Choi, KS [1 ]
机构
[1] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea
[2] Ajou Univ, Dept Surg, Sch Med, Suwon 441749, South Korea
[3] Keimyung Univ, Dept Immunol, Sch Med, Taegu, South Korea
[4] Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul, South Korea
关键词
D O I
10.1158/0008-5472.CAN-05-1568
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sulforaphane is a chemopreventive agent present in various cruciferous vegetables, including broccoli. Here, we show that treatment with tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in combination with subtoxic doses of sulforaphane significantly induces rapid apoptosis in TRAIL-resistant hepatoma cells. Neither TNF-alpha- nor Fas-mediated apoptosis was sensitized in hepatoma cells by cotreatment with sulforaphane, suggesting that sulforaphane can selectively sensitize cells to TRAIL-induced apoptosis but not to apoptosis mediated by other death receptors. We found that sulforaphane treatment significantly up-regulated mRNA and protein levels of DR5, a death receptor of TRAIL. This was accompanied by an increase in the generation of reactive oxygen species (ROS). Pretreatment with N-acetyl-L-cysteine and overexpression of catalase inhibited sulforaphane-induced up-regulation of DR5 and almost completely blocked the cotreatment-induced apoptosis. Furthermore, the sulforaphane-mediated sensitization to TRAIL was efficiently reduced by administration of a blocking antibody or small interfering RNAs for DR5. These results collectively indicate that sulforaphane-induced generation of ROS and the subsequent up-regulation of DR5 are critical for triggering and amplifying TRAIL-induced apoptotic signaling. We also found that sulforaphane can sensitize both Bcl-xL- and Bcl-2-overexpressing hepatoma cells to TRAIL-induced apoptosis, indicating that treatment with a combination of TRAIL and sulforaphane may be a safe strategy for treating resistant hepatomas.
引用
收藏
页码:1740 / 1750
页数:11
相关论文
共 53 条
[21]   Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution [J].
Kelley, RF ;
Totpal, K ;
Lindstrom, SH ;
Mathieu, M ;
Billeci, K ;
DeForge, L ;
Pai, R ;
Hymowitz, SG ;
Ashkenazi, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) :2205-2212
[22]   Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP [J].
Kim, EH ;
Kim, SU ;
Shin, DY ;
Choi, KS .
ONCOGENE, 2004, 23 (02) :446-456
[23]   Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells [J].
Kim, YH ;
Park, JW ;
Lee, JY ;
Kwon, TK .
CARCINOGENESIS, 2004, 25 (10) :1813-1820
[24]   TRAIL-mediated apoptosis requires NF-κB inhibition and the mitochondrial permeability transition in human hepatoma cells [J].
Kim, YS ;
Schwabe, RF ;
Qian, T ;
Lemasters, JJ ;
Brenner, DA .
HEPATOLOGY, 2002, 36 (06) :1498-1508
[25]   Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 [J].
Kischkel, FC ;
Lawrence, DA ;
Chuntharapai, A ;
Schow, P ;
Kim, KJ ;
Ashkenazi, A .
IMMUNITY, 2000, 12 (06) :611-620
[26]   Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax [J].
LeBlanc, H ;
Lawrence, D ;
Varfolomeev, E ;
Totpal, K ;
Morlan, J ;
Schow, P ;
Fong, S ;
Schwall, R ;
Sinicropi, D ;
Ashkenazi, A .
NATURE MEDICINE, 2002, 8 (03) :274-281
[27]   The TNF and TNF receptor superfamilies: Integrating mammalian biology [J].
Locksley, RM ;
Killeen, N ;
Lenardo, MJ .
CELL, 2001, 104 (04) :487-501
[28]   Mechanism of oxidative DNA damage induced by carcinogenic allyl isothiocyanate [J].
Murata, M ;
Yamashita, N ;
Inoue, S ;
Kawanishi, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (05) :797-805
[29]   Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells [J].
Nakata, S ;
Yoshida, T ;
Horinaka, M ;
Shiraishi, T ;
Wakada, M ;
Sakai, T .
ONCOGENE, 2004, 23 (37) :6261-6271
[30]  
NISHIDA N, 1993, CANCER RES, V53, P368